Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$3.15M Buy
26,473
+8,540
+48% +$940K 0.05% 602
2017
Q3
$1.71M Buy
17,933
+3,027
+20% +$292K 0.03% 721
2017
Q2
$1.42M Buy
14,906
+9,068
+155% +$775K 0.03% 689
2017
Q1
$453K Buy
+5,838
New +$405K 0.01% 979
2016
Q4
Sell
-5,207
Closed -$312K 1107
2016
Q3
$312K Buy
5,207
+246
+5% +$13.7K 0.01% 973
2016
Q2
$249K Buy
+4,961
New +$237K 0.01% 740

Other funds holding INGN

AHL Partners's INGN Position: Q4 2017 in Review

AHL Partners increased its Inogen (INGN) stake by 48% in Q4 2017, buying an estimated $940K and bringing the position to 26,473 shares worth $3.15M. The position accounts for 0.05% of the portfolio, ranked #602.

AHL Partners first reported a position in INGN in Q2 2016 and has held it in 6 quarters since. 220 funds tracked by Wall St. Rank hold INGN as of Q4 2017.

  • AHL Partners held 26,473 shares of Inogen worth $3.15M as of Q4 2017.
  • AHL Partners bought 8,540 Inogen shares in Q4 2017, an estimated $940K.
  • Inogen made up 0.05% of AHL Partners's portfolio in Q4 2017, its #602 holding.
  • AHL Partners first reported a position in Inogen in Q2 2016 and has held it in 6 quarters since.
  • 220 funds tracked by Wall St. Rank held Inogen as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.